Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey by Marta Vernero, Cristina Bezzio, Davide G. Ribaldone, Flavio A. Caprioli, Massimo C. Fantini, Stefano Festa, Fabio S. Macaluso, Ambrogio Orlando, Daniela Pugliese, Sara Renna, Antonio Rispo, Edoardo V. Savarino, Angela Variola, Simone Saibeni

“…Designated appointment slots for rheumatologists and dermatologists were accessible to 72.2% and 58.2% of physicians, respectively, while 20.1% had no access to designated slots. …”
Get full text

PHARMACOTHERAPY FOR RHEUMATOID ARTHRITIS: RUSSIAN AND INTERNATIONAL GUIDELINES by E. L. Nasonov

“…The lecture considers the present trends in the strategy of pharmacotherapy for rheumatoid  arthritis (RA) in the light of the guidelines by the European  League Against Rheumatism, the American College of Rheumatology and the All-Russian Public Organization  "The Association of Rheumatologists  of Russia". It emphasizes the most important  role of the treat-to-target RA treatment strategy, the key place of which is occupied by early controlled  active therapy with methotrexate (MT).  …”
Get full text

Certolizumab-Induced Uveitis: A Case Report and Review of the Literature by Elad Moisseiev, Shiri Shulman

“…Awareness of the possibility of this unique complication is important for both rheumatologists and ophthalmologists who treat patients with this new agent.…”
Get full text

Archibald Edward Garrod, combining clinical practice with research by Antonio Iglesias, Estefania Fajardo, Carlo V Caballero-Uribe

“…"This physician, born in 1857, argued that rheumatoid arthritis was essentially a disease of the joints and should be clearly distinguished from rheumatism. " Editor's note: The note on Archibald Edward Garrod is the final entry of the initial series of History of Rheumatology with characters spanning the 17th century (Sydenham), 18th century (Heberden), 19th century (Osler and Garrod Sr.) and early 20th century (Garrod Jr.), constituting the legacy for Western rheumatology of what some have called the “proto-rheumatologists” or forerunners of the specialty.…”
Get full text

Systemic vasculitis in a patient with rhupus syndrome by O. Zengin, M. E. Onder, M. A. Sarica, I. H. Turkbeyler, G. Kimyon, Z. H. Demir, H. Yildiz, B. Kisacik, A. M. Onat

“…Our patient diagnosed as rhupus was a young women, presented with multi-organ involvement of systemic vasculitis. Rheumatologists should be aware of possibility that rhupus may be accompanied by progressive or life-threatening conditions such as vasculitis.…”
Get full text

ERYTHEMA NODOSUM: VASCULITIS OR PANNICULITIS? by Boris Sergeyevich Belov, O N Egorova, S G Radenska-Lopovok, R M Balabanova, E G Sazhina, M E Tsanyan

“…The long-term study of the disease by rheumatologists, pulmonologists, dermatologists, and other specialists has allowed them to state a variety of etiotropic factors and polymorphism of its clinical symptomatology. …”
Get full text

DRUG-INDUCED ENCEPHALOPATHY WITH IMPAIRED COGNITIVE FUNCTIONS DURING TOCILIZUMAB USE by P. A. Shesternya, S. V. Prokopenko, E. Yu. Mozheiko, O. D. Gritsenko, T. V. Tupaeva, E. M. Kurts

“…Tocilizumab (TCZ), the first registered anti-IL-6 receptor monoclonal antibody, has been used effectively by rheumatologists since 2010. During this period, the spectrum of adverse reactions (ARs) of TCZ has been clearly defined. …”
Get full text

15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

“…This congress unites the scientists and physicians of Mediterranean countries and focuses the attention of rheumatologists and allied health professionals on the geographical and ethnical features of the pattern of human diseases caused by the inflammatory and metabolic involvement of the locomotor apparatus, as well as the peculiarity of the course of rheumatic diseases and treatment response. …”
Get full text

Chikungunya fever: rheumatological aspects by В. S. Belov, D. V. Bukhanova, G. M. Tarasova

“…CF is of undoubted interest for rheumatologists primarily due to the development of severe joint syndrome (arthralgia/arthritis) developing at all stages of the disease. …”
Get full text

Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype by L. P. Ananieva, S. N. Avdeev, I. Е. Tyurin, A. М. Lila, A. I. Zagrebneva, А. L. Maslyanskiy, S. A. Terpigorev, I. V. Stepanyan, E. L. Lashina, O. V. Vasilieva, O. S. Lukina, E S. Pershina, А. А. Klimenko, N. A. Shostak, E. L. Nasonov

“…The problem of fibrosing interstitial lung diseases (ILDs) unites specialists from different areas: pulmonologists, radiologists, therapists, rheumatologists, occupational doctors and others. Actual achievements in studying fibrosing ILDs which are connected with development of immunology and molecular biological methods for the determination of biomarkers, new principles of image-diagnostics of lung pathology, search of new therapeutic “targets”, dictate the necessity of integration of knowledge by specialists from different areas of medicine for improvement pharmacotherapy algorithms. …”
Get full text

Women in rheumatology: major contributions and key discoveries of the twentieth century by Ishchenko, A, Scriffignano, S, Coates, L

“…We hope that the achievements of these remarkable women will inspire young rheumatologists and researchers.…”

The Swiss Systemic lupus erythematosus Cohort Study (SSCS) – cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland... by Camillo Ribi, Marten Trendelenburg, Angèle Gayet-Ageron, Clemens Cohen, Eric Dayer, Ute Eisenberger, Thomas Hauser, Thomas Hunziker, Annette Leimgruber, Gregor Lindner, Katrin Koenig, Petra Otto, François Spertini, Thomas Stoll, Johannes Von Kempis, Carlo Chizzolini, Swiss Systemic Lupus Erythematosus Cohort Study Group

“…Anti-malarial drugs were mostly prescribed by rheumatologists and internists and less frequently by nephrologists, and appeared to be associated with less active SLE. …”
Get full text

Women in Rheumatology in the Arab League of Associations for Rheumatology Countries: A Rising Workforce by Nelly Ziade, Ihsane Hmamouchi, Lina El Kibbi

“…BackgroundAn increase in women physicians in the medical workforce is witnessed in recent decades, paralleled by an increase in leadership positions and, to a lesser extent, in academic advancement.ObjectivesThis study aims to evaluate the women rheumatologists (WR) workforce and to identify the challenges faced by WR in the Arab League of Associations for Rheumatology (ArLAR) countries.MethodsWe collected data from members of special interest groups from 16 ArLAR countries about the number of rheumatologists in the national societies and boards – including WR –, and the estimated percentage of WR involved in academia. …”
Get full text

Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis by Jeffrey R. Curtis, Vibeke Strand, Steven J. Golombek, George A. Karpouzas, Lixia Zhang, Angus Wong, Krishna Patel, Jennifer Dines, Viatcheslav R. Akmaev

“…Conclusion This study showed that rheumatologists reported using the MSRC test to guide b/tsDMARD selection for patients with RA. …”
Get full text

PRIMARY SJOGREN'S SYNDROME ASSOCIATED WITH ANTICENTROMERE ANTIBODIES by B. D. Chaltsev

“…Anti-centromere antibody (ANCA) seropositivity is generally regarded by rheumatologists as a sign of systemic sclerosis (SS) in clinical practice. …”
Get full text

THE 50th ANNIVERSARY OF THE DEPARTMENT OF ORTHOPEDIC RHEUMATOLOGY, V.A. NASONOVA RESEARCH INSTITUTE OF RHEUMATOLOGY: RESULTS AND PROSPECTS by V. P. Pavlov

“…In connection with such a remarkable date the author sums up some results of the scientific and practical activities of the orthopedic rheumatologists of the V.A. Nasonova Research Institute of Rheumatology and considers the prospects for further research developments, the possible evolution of minimally invasive surgery (arthroscopic technology for the treatment of large and small joints), and the issues of rehabilitation in a wide range of rheumatic diseases, by applying high technology.…”
Get full text

A case report of an extremely rare association of ankylosing spondylitis with pachydermoperiostosis by Faiq I. Gorial, Nabaa Ihsan Awadh, Maryam A. Hamzah

“…By describing this rarity, we aim to help build a database for future studies and construct a management plan that rheumatologists and clinicians can use. Abstract This is the first case report in Iraq describing the combination of pachydermoperiostosis and ankylosing spondylitis. …”
Get full text

The problem of musculoskeletal pain: what is interesting for the practitioner? Data of a survey of 846 Russian physicians by A. E. Karateev

“…The paper presents the results of a survey of 846 Russian physicians (neurologists, rheumatologists, orthopedic traumatologists, general practitioners, and therapists), whose work is associated with the treatment of musculoskeletal pain. …”
Get full text

15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

“…This congress unites the scientists and physicians of Mediterranean countries and focuses the attention of rheumatologists and allied health professionals on the geographical and ethnical features of the pattern of human diseases caused by the inflammatory and metabolic involvement of the locomotor apparatus, as well as the peculiarity of the course of rheumatic diseases and treatment response. …”
Get full text

Lung Injury Induced by Antitumor Drugs: Prevalence, Certain Drugs and Their Mechanisms of Action. Part 2 by N. V. Orlova, O. D. Ostroumova, E. V. Shikh, S. V. Smerdin, E. V. Rebrova, V. А. Dyo

“…The prevention of drug-induced lung injury requires raising awareness among practicing physicians of different specialties, primarily general practitioners, rheumatologists, clinical immunologists, pulmonologists, phthisiologists, and oncologists due to non-specific manifestations of drug-induced lung injury and the use of antitumor drugs for other diseases apart from cancer.…”
Get full text